The inhibition of the potassium channel TASK-1 in rat cardiac muscle by endothelin-1 is mediated by phospholipase C

Cardiovasc Res. 2013 Jan 1;97(1):97-105. doi: 10.1093/cvr/cvs285. Epub 2012 Sep 12.

Abstract

Aims: The two-pore-domain potassium channel TASK-1 is robustly inhibited by the activation of receptors coupled to the Gα(q) subgroup of G-proteins, but the signal transduction pathway is still unclear. We have studied the mechanisms by which endothelin receptors inhibit the current carried by TASK-1 channels (I(TASK)) in cardiomyocytes.

Methods and results: Patch-clamp measurements were carried out in isolated rat cardiomyocytes. I(TASK) was identified by extracellular acidification to pH 6.0 and by the application of the TASK-1 blockers A293 and A1899. Endothelin-1 completely inhibited I(TASK) with an EC(50) of <10 nM; this effect was mainly mediated by endothelin-A receptors. Application of 20 nM endothelin-1 caused a significant increase in action potential duration under control conditions; this was significantly reduced after pre-incubation of the cardiomyocytes with 200 nM A1899. The inhibition of I(TASK) by endothelin-1 was not affected by inhibitors of protein kinase C or rho kinase, but was strongly reduced by U73122, an inhibitor of phospholipase C (PLC). The ability of endothelin-1 to activate PLC-mediated signalling pathways was examined in mammalian cells transfected with TASK-1 and the endothelin-A receptor using patch-clamp measurements and total internal reflection microscopy. U73122 prevented the inhibition of I(TASK) by endothelin-1 and blocked PLC-mediated signalling, as verified with a fluorescent probe for phosphatidylinositol-(4,5)-bisphosphate hydrolysis.

Conclusion: Our results show that I(TASK) in rat cardiomyocytes is controlled by endothelin-1 and suggest that the inhibition of TASK-1 via endothelin receptors is mediated by the activation of PLC. The prolongation of the action potential observed with 20 nM endothelin-1 was mainly due to the inhibition of I(TASK).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials
  • Animals
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Endothelin-1 / pharmacology*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Hydrogen-Ion Concentration
  • Hydrolysis
  • Ion Channel Gating*
  • Kinetics
  • Microscopy, Fluorescence
  • Microscopy, Interference
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / enzymology*
  • Nerve Tissue Proteins
  • Patch-Clamp Techniques
  • Phosphatidylinositol 4,5-Diphosphate / metabolism
  • Potassium Channel Blockers / pharmacology*
  • Potassium Channels, Tandem Pore Domain / antagonists & inhibitors*
  • Potassium Channels, Tandem Pore Domain / genetics
  • Potassium Channels, Tandem Pore Domain / metabolism
  • Rats
  • Receptor, Endothelin A / genetics
  • Receptor, Endothelin A / metabolism
  • Signal Transduction / drug effects
  • Transfection
  • Type C Phospholipases / antagonists & inhibitors
  • Type C Phospholipases / metabolism*

Substances

  • Endothelin-1
  • Enzyme Inhibitors
  • Nerve Tissue Proteins
  • Phosphatidylinositol 4,5-Diphosphate
  • Potassium Channel Blockers
  • Potassium Channels, Tandem Pore Domain
  • Receptor, Endothelin A
  • potassium channel subfamily K member 3
  • Type C Phospholipases